Cephalon Goes After Lupin In 6th Nuvigil Patent Suit
Cephalon Inc. has filed yet another patent infringement suit to keep generic versions of popular narcolepsy and sleep apnea drug Nuvigil off the market, this time targeting Lupin Pharmaceuticals Inc....To view the full article, register now.
Already a subscriber? Click here to view full article